NCT02015715View on ClinicalTrials.gov

A Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of RO6864018 in Male, Healthy, Asian Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions

Healthy Volunteer

Interventions

DRUG

RO6864018

A single oral ascending dose of RO6864018 capsules on Day 1.

DRUG

Placebo

A single oral dose of placebo matching RO6864018 capsules on Day 1.

Trial Locations (2)

529889

Changi General Hospital; Clinical Trial & Research unit, Singapore

Singapore

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY

NCT02015715 - A Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of RO6864018 in Male, Healthy, Asian Participants | Biotech Hunter | Biotech Hunter